MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-23-2026
Emergent BioSolutions ROCE Ratio 2011-2026 | EBS
Annual ROCE Ratio Emergent BioSolutions
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.15 | -22.51 | -111.87 | -12.25 | 21.19 | 30.22 | 5.41 | 4.43 | 12.81 | 12.21 | 10.17 | 6.81 | 7.51 | 7.88 | 6.75 | 19.91 | 16.47 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.22 | -111.87 | 2.02 |
Quarterly ROCE Ratio Emergent BioSolutions
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.47 | 35.15 | -30.67 | -24.97 | -68.72 | -112.04 | -71.67 | -80.83 | -45.7 | -17.35 | -5.03 | -4.09 | -0.93 | 5.33 | 4.93 | 22.76 | 29.28 | 37.05 | 29.98 | 19.29 | 21.55 | 12.2 | 10.48 | 5.44 | 5.55 | 5.12 | 7.64 | 12.87 | 11.7 | 6.73 | 7.8 | 13.76 | 8.18 | 10.79 | 9.16 | 16.72 | 20.33 | 23.93 | 16.09 | 16.6 | 13.07 | 11.44 | 10.39 | 7.09 | 4.74 | 6.14 | 8.74 | 9.43 | 7.95 | 6.9 | 6.79 | 12.45 | 10.56 | 13.48 | 7.75 | 0.34 | 4.88 | -8.57 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 37.05 | -112.04 | 2.11 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-73.94 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-5.51 | $ 5.6 | - | $ 83.2 M | USA |
 |
HEXO Corp.
HEXO
|
-340.37 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-33.39 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
-207.12 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
-1.59 | $ 2.63 | -1.87 % | $ 1.01 B | Canada |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
58.18 | $ 38.93 | 3.43 % | $ 1.43 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
14.89 | $ 2.41 | 2.99 % | $ 305 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 22.74 | -1.09 % | $ 1.05 B | USA |
 |
Canopy Growth Corporation
CGC
|
-23.17 | $ 0.98 | -1.71 % | $ 105 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | $ 1.11 | 1.83 % | $ 1.38 M | USA |
 |
Aurora Cannabis
ACB
|
0.81 | $ 2.95 | -2.96 % | $ 162 M | Canada |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 7.36 | 3.08 % | $ 644 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
-11.66 | $ 1.03 | -2.83 % | $ 98.2 M | Canada |
 |
Tilray
TLRY
|
-41.31 | $ 5.01 | 0.6 % | $ 3.1 B | Canada |
 |
Evolus
EOLS
|
141.36 | $ 6.75 | 0.3 % | $ 435 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.43 | 0.7 % | $ 3.37 M | Canada |
 |
Veru
VERU
|
-135.01 | $ 3.13 | 4.33 % | $ 45.8 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-39.01 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
-29.93 | $ 0.67 | -2.33 % | $ 2.7 M | USA |
 |
Assertio Holdings
ASRT
|
-22.92 | $ 23.5 | 0.09 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
-265.79 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
-327.26 | $ 4.99 | -1.38 % | $ 1.85 B | Canada |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 6.37 | -4.21 % | $ 251 M | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
40.43 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 4.09 | -3.31 % | $ 204 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
-18.1 | $ 16.32 | -0.97 % | $ 19 B | USA |
 |
Zomedica Corp.
ZOM
|
-73.1 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-12.68 | $ 0.64 | 2.74 % | $ 23 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.24 | $ 0.75 | 2.35 % | $ 3.22 M |  China |
 |
TherapeuticsMD
TXMD
|
-16.33 | $ 2.28 | 3.64 % | $ 26.4 M | USA |